Yahoo Poland Wyszukiwanie w Internecie

Search results

  1. The Breast Cancer Risk Assessment Tool (BCRAT), also known as The Gail Model, allows health professionals to estimate a woman's risk of developing invasive breast cancer over the next five years and up to age 90 (lifetime risk).

    • Risk Calculator

      This tool cannot accurately calculate risk for women with a...

    • The Gail Model

      Learn how the Gail model-based Breast Cancer Risk Assessment...

  2. The Gail Model is for use in women with no history of breast cancer, DCIS or LCIS. Other tools may be more appropriate for women with known mutations in BRCA1, BRCA2, or other hereditary syndromes associated with breast cancer. See the Evidence section for more information.

  3. 11 lis 2018 · For preventing and screening of breast cancer, estimation of risk of breast cancer in Turkish population is crucial., Our study indicates that Gail model is a reliable and useful breast cancer risk prediction model for clinical decision-making.

  4. 7 mar 2001 · Statisticians modified the original Gail et al. model to predict specifically the risk of developing invasive breast cancer. This modified model, referred to as “model 2” (2), was used to determine eligibility for the Breast Cancer Prevention Trial (BCPT) (3).

  5. 22 kwi 2020 · The Breast Cancer Risk Assessment Tool (BCRAT), also known as the Gail model (GM) (available at http://www.cancer.gov/bcrisktool/), is the most commonly used to predict breast cancer risk and was originally developed for use in white females to estimate breast cancer risk .

  6. 13 mar 2018 · The Breast Cancer Risk Assessment Tool (BCRAT) , also known as the Gail model, was the most widely used appraisal tool for predicting the absolute risk of developing breast cancer. Individuals with 5-year risk exceeding 1.67% were considered high risk [ 3 ].

  7. 24 lut 2021 · In a study conducted in Brazil, Clementino et al., (2013) compared the Gail model with the Claus, BRCAPRO, and BOADICEA models in estimating the risk of breast cancer and the probability of risk conferred by the BRCA 1/2 mutation, correlating the values found in the different models.